Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

PURPOSE: We prospectively conducted a multi-center, open-label, randomized phase II trial to compare the efficacy and safety of docetaxel plus cisplatin (DC) and etoposide plus cisplatin (EC) for treating advanced stage non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Seventy-eight previou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Nam-Su, Park, Hee-Sook, Won, Jong-Ho, Hong, Dae-Sik, Uh, Su-Taek, Lee, Sang-Jae, Kim, Joo-Hang, Kim, Se-Kyu, Ahn, Myung-Ju, Choi, Jung-Hye, Yang, Suk-Chul, Lee, Jung-Ae, Lee, Keun-Seok, Yim, Chang-Yeol, Lee, Yong-Chul, Kim, Chul-Soo, Lee, Moon-Hee, Jung, Kab-Do, Moon, Hanlim, Lee, Yl-Sub
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Cancer Association 2005
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785933/
https://ncbi.nlm.nih.gov/pubmed/19956368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2005.37.6.332
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak